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ABSTRACT 
Flavonoids are a group of plant metabolites with antioxidant effects. One of the most abundant flavonoids in the human 
diet is quercetin. It is found widely in fruits, vegetables and has a lot of beneficial effects on human health. Quercetin has a 
positive pharmacological effect on bone metabolism and it prevents the organism against bone loss. However, its impact on 
the size of basic structural units of the compact bone is still unknown. Therefore, the aim of present study was to 
investigate the impact of the quercetin on femoral bone microstructure in 5-month-old male rabbits. Five rabbits of 
Californian broiler line were randomly divided into two groups. In the experimental group (E group; n=3), animals were 
intramuscularly injected with quercetin at dose 1000 μg.kg-1 body weight (bw) for 90 days, 3 times per week. Two rabbits 
without quercetin administration served as a control group (C group). According to our results, intramuscular application of 
quercetin had an insignificant effect on cortical bone thickness in male rabbits. In these rabbits, changes in qualitative 
histological characteristics were present in the middle part of the compacta, where primary vascular longitudinal bone 
tissue was present and expanded there from the periosteum. Also, a lower number of secondary osteons was found in these 
animals. From the histomorphometrical point of view, significantly decreased sizes of primary osteons’ vascular canals and 
secondary osteons (p <0.05) were found in rabbits administered by quercetin. Our findings indicate that subchronic 
administration of quercetin at the dose used in our study had considerable impact on both qualitative and quantitative 
histological characteristics of the compact bone in adult male rabbits. 
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INTRODUCTION 
 Flavonoids are a group of natural polyphenolic 
substances which consists of two aromatic rings linked by 
3 carbons, usually in an oxygenated heterocycle ring (Liu, 
2004). These aromatic secondary plant metabolites have 
been recognized as important bioactive compounds due to 
their physiological and pharmacological role, and their 
health benefits (Hooper and Cassidy, 2006). Fruits and 
vegetables, tea, and cocoa are rich natural sources of 
flavonoids (Chen et al., 2010; Egert and Rimbach, 2011; 
Sekeroğlu and Sekeroğlu, 2012). In human diet, one of 
the most important vegetable with rich content of 
antioxidant polyphenols is onion. The results by 
Kavalcová et al. (2015) showed that a higher content of 
polyphenols and thus, a higher antioxidant activity have 
more colorful varieties of onions. According to 
Danihelová and Šturdík (2011), average daily intake of 
flavonoids is strongly dependent on individual, country 
and culture usages. It is approximately in the range of 150 
to 300 mg/day 
 In nature, flavonoids are most frequently found as 
conjugates in glycosylated or esterified forms; however, 
they can occur as aglycones, especially as a result of the 
effects of food processing (Aggarwal and Heber, 2014). 
Many flavonoids are shown to have antioxidative activity, 
free-radical scavenging capacity, coronary heart disease 
prevention, and anticancer activity (Yao et al., 2004). 
Their antioxidant capacity is associated with the presence 
of series of structural characteristics (most probably 
related to the phenolic hydroxyl groups attached to the ring 
structure) that allow them to quelate ions of transition 
metals such as Fe2+, Cu2+, or Zn2+ and to catalyze the 
electron transport (Braun et al., 2011).  Moreover, they 
are able to inhibit lipid peroxidation and platelet 
aggregation and improve increased capillary permeability 
and fragility (Hubbard et al., 2004; Cirico and Omaye, 
2006).  
 In the recent past, dietary supplements of flavonoids, as 
their alternative sources, have become increasingly 
popular. However, it is important to point out that natural 
sources of flavonoids contain a complex mixture of 
secondary plant metabolites and not only flavonoids per se 
(Crassidy et al., 2011). This complex mixture cannot be 
simply exchanged by single purified substances as dietary 
supplements. Therefore, it is very essential to evaluate 
possible adverse effects of purified flavonoids as dietary 
supplements on human health. Indeed, there is growing 
evidence that purified flavonoids given in high doses may 
affect trace element, folate, and vitamin C status. Also, 
they can exhibit antithyroid and goitrogenic activities 
(Egert and Rimbach, 2011).  
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 One of the most widely distributed flavonoid in plants is 
quercetin (3, 3', 4', 5, 7-pentahydroxyflavone; Liang et al., 
2011). Quercetin is found in many common foods 
including apples, tea, onions, nuts, berries, cauliflower, 
cabbage and many other foods (Lakhanpal and Rai, 
2007). The normal intake of quercetin is less than  
5-40 mg/day. However, people who eat the peel of food 
with high amounts of quercetin may consume  
200-500 mg/day (Harwood et al., 2007). Only 30-50% of 
ingested quercetin is absorbed, the rest passes through 
gastro-intestinal tract (Ross and Kasum, 2002). 
 Quercetin has a broad range of significant health 
promoting properties (Agullo et al. 1997; Verhoeyen et 
al., 2002; Boots et al., 2007). According to several authors 
(Formica and Regelson, 1995; Manach et al., 1996; 
Boik, 2001; Satyanarayana et al., 2001; Brookes et al., 
2002; Davis et al., 2009; Wein et al., 2013; Wu et al., 
2014; Forte et al., 2016) quercetin has cardioprotective, 
anticarcinogenogenic, antioxidant, anti-inflammatory, 
antibacterial and antiapoptic properties. It facilitates 
apoptosis of tumor cells, in part through depression of an 
endogenous cytoprotective molecule, heat shock protein 
70 (Hosokawa et al., 1990). As well, quercetin may 
inhibit apoptosis in some nontumorigenic cells. For 
example, quercetin inhibits hydrogen peroxide (H2O2) 
induced apoptosis of mesangial cells, fibroblasts and 
epithelial cells (Ishikawa and Kitamura, 2000).  
 This flavonoid also disposes reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) scavenging 
activity (Heijnen et al., 2001; Nickel et al., 2011; 
Dehghan and Khoshkam, 2012) under in vitro and in 
vivo conditions (Choi et al., 2001; Nabavi et al., 2012). 
Therefore, it has often been associated with the reduced 
risk of oxidative-stress related chronic diseases such as 
coronary heart disease, stroke and diabetes (Skibola and 
Smith, 2000).   
 On the other hand, quercetin has potentially toxic effects, 
including its mutagenicity, prooxidant activity, 
mitochondrial toxicity, and inhibition of key enzymes 
involved in hormone metabolism (Okamoto, 2005; Zhang 
et al., 2009). Dunnick and Hailey (1992) reported that 
high doses of quercetin over several years might result in 
the formation of tumors in the kidney of rats. The results 
by Rise et al. (2006) showed that quercetin can modulate 
ovarian functions by interfering with cell steroidogenic 
activity and angiogenic activity. Quercetin can also be a 
potential neurotoxic substance (Jakubowicz-Gil et al., 
2008). According to Robaszkiewicz et al. (2007), 
quercetin-induced antioxidant or prooxidant effects are 
largely relates to its dose given to biological system. At 
concentrations > 50 μM, quercetin is able to participate in 
the oxidation of NADPH in liver cells, shifting the cellular 
conditions to a more oxidized states (Buss et al., 2005).  
 Regarding the bone, quercetin has a positive 
pharmacological effect on bone metabolism and it prevents 
the organism against bone loss (Boots et al., 2007; 
Sharan et al., 2011). It inhibits mRNA expression of 
osteoclast-related genes and osteoclast differentiation, 
thereby reduces bone resorption (Guo et al., 2012).  
 The studies by Notoya et al. (2004) and Wattel et al. 
(2004) revealed that inhibitory potential of quercetin on in 
vitro osteoclastic differentiation is connected via a 
mechanism involving NF kappa B and activator protein 1 
(AP-1). Also, increased alkaline phosphatase activity in 
MG-63 osteoblasts followed by quercetin application was 
demonstrated (Robaszkiewicz et al., 2007). Zhou and 
Lin (2014) reported that quercetin could enhance the 
osteogenic differentiation of adipose-derived stem cells 
(ASCs) and osteoblastic MC3T3-E1 cells and inhibit 
osteoclastogenesis in RAW 264.7 cells. Moreover, it could 
stimulate Osterix (Osx), BMP-2, Runx2, OCN, OPN, 
COL1 and ALP gene expression in ASCs, and increase 
bone sialoprotein (BSP) and OCN gene expression in 
osteoblastic MC3T3-E1 cells (Kim et al., 2006; Satué et 
al., 2013). However, the effect of quercetin on osteoblast 
function is contradictory (Yamaguchi and Weitzmann, 
2011). According to Prouillet et al. (2004) it stimulates 
proliferation and differentiation of rat calvarial osteoblasts 
and MG-63 osteoblast-like cells. Braun et al. (2011) have 
found protective effect of quercetin on primary human 
osteoblasts against the toxic influence of cigarette smoke. 
This fact indicates that a dietary supplementation with 
quercetin could improve bone structure, skeletal integrity, 
and even fracture healing in smokers. On the contrary to 
above findings, Kanno et al. (2004) mention that 
quercetin induces apoptosis of MC3T3-E1 mouse calvarial 
osteoblasts. Notoya et al. (2003) found that it inhibited not 
only the proliferation but also the differentiation and 
mineralization of of rat calvarial osteoblast-like cells 
(ROB cells; Hagiwara et al., 1996; Partridge et al., 
1981). Quercetin-induced apoptosis (through a 
mitochondria-dependent mechanism involving ERK 
activation) and inhibition of migration (through activation 
of ERK and p38 pathways) of osteoblasts were also 
showed in the research by Nam et al. (2008). 
 The impact of quercetin on histomorphometry of basic 
structural units of the compact bone is still unknown. 
Therefore, the aim of our study was to investigate the 
effect of intramuscular application of quercetin on femoral 
bone microstructure in adult male rabbits. 
 
MATERIAL AND METHODOLOGY 
 Our research was carried out on five male rabbits of meat 
line M91, maternal albinotic line (crossbreed New Zealand 
White, Buskat rabbit, French Silver) and paternal 
acromalictic line (crossbreed Nitra’s rabbit, Californian 
rabbit, Big Light Silver) of approximately 5 months of age, 
with a body weight 4.00 ±0.5 kg. Animals were obtained 
from an experimental farm of the Animal Production 
Research Centre in Nitra (Slovak Republic) and were 
housed in individual flat-deck wire cages. The animals 
were maintained under constant conditions of light  
(12-h light/12-h dark), temperature (20-24 °C) and 
humidity (55% ±10%), with access to food (feed mixture) 
and drinking water ad libitum. The rabbits were randomly 
assigned into two groups. In the first group (E group; n=3), 
quercetin was applied intramuscularly in the concentration 
of 1000 µg.kg-1bw 3 times per week, for 90 days. The dose 
of quercetin (reflecting the constant exposure of animals to 
quercetin in rabbit feed) was chosen based on the literature 
data (Choi and Li, 2005; Knab et al., 2011;  
Lesniak-Walentyn et al., 2013). Two rabbits without 
quercetin application served as a control group (C group). 
Institutional and national guidelines for the care and use of 
animals were followed, and all experimental procedures 
were approved by the State Veterinary and Food Institute 
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of Slovak Republic, no. 3398/11-221/3 and ethics 
committee. 
 At the end of experimental period (after 90 days), all 
rabbits were killed and their femora were used for 
histological analyses. Thin sections from femora were 
prepared according to the methodology of Martiniaková 
et al. (2008). The qualitative histological characteristics of 
compact bone were determined according to the 
internationally accepted classification systems of Enlow 
and Brown (1956) and de Ricqlés et al. (1991), who 
classified bone tissue into three broad categories: primary 
vascular tissue, non-vascular tissue and Haversian bone 
tissue. The quantitative (histomorphometrical) variables 
were assessed using the software Motic Images Plus  
2.0 ML (Motic China Group Co., Ltd.). We measured area, 
perimeter, and minimum and maximum diameters of 
primary osteons’ vascular canals, Haversian canals, and 
secondary osteons in all fields (i.e., anterior, posterior, 
medial and lateral) of the thin sections. The diaphyseal 
cortical bone thickness was also measured by Motic 
Images Plus 2.0 ML software. Twenty random areas were 
selected, and average thickness was calculated for each 
femur. 
 Statistical analysis was performed using SPSS 8.0 
software. All data were expressed as mean ±standard 
deviation (SD). The unpaired t-test was used for 
establishing statistical significance (p <0.05) between both 
groups of rabbits.  
 
RESULTS AND DISCUSSION 
 Our results showed an insignificant effect of quercetin on 
cortical bone thickness in male rabbits  
(1035.56 ±159.42 µm and 1025.06 ±209.09 µm in rabbits 
from E and C groups, respectively).   
 Compact bone microstructure in rabbits from C group 
(Fig.1) was formed near endosteal bone surfaces by 
primary vascular radial, irregular Haversian and/or dense 
Haversian bone tissues. The middle part of the compact 
bone considered of a layer of irregular and/or dense 
Haversian bone tissues. Secondary osteons were often 
connected with Volkmann’s canals. The periosteal bone 
surface mostly consisted of primary vascular longitudinal 
bone tissue; irregular Haversian bone tissue was observed 
only in anterior side. These findings are consistent with the 
results of several authors (Enlow and Brown, 1958; 
Martiniaková et al., 2003; Martiniaková et al., 2006).  
 In rabbits from E group, endosteal bone surface was 
composted by primary vascular radial and irregular 
Haversian bone tissues. Primary vascular longitudinal 
bone tissue was in some areas (anterior and posterior) near 
endosteal surface completely resorbed. The rabbits 
intramuscularly administered by quercetin had fewer  
secondary osteons in the middle part of substantia 
compacta because primary vascular longitudinal bone 
tissue expanded into this part of bone from periosteum.  
The periosteal border was formed only by primary 
vascular longitudinal bone tissue (Fig. 2).  
 Intramuscular administration of quercetin caused evident 
alterations in femoral bone microstructure of male rabbits. 
A lower number of secondary osteons in the middle parts 
of the substantia compacta could be associated with 
accelerated bone resorption. ROS have been reported to 
play a crucial role in the process of bone resorption 
(Halliwell et al., 1992; Yang et al., 1998). During this 
process, osteoclasts produce large amounts of ROS, and 
their excessive accumulation inhibits bone formation and 
stimulates further bone resorption (Baek et al., 2010). 
Quercetin has been described as the protector against ROS 
RNS (Nickel et al., 2011; Kovacevic and Matulic, 2013). 
However, quercetin has the potential to produce ROS at 
high doses (Rahman et al., 1992). In the process of 
scavenging reactive species, quercetin may be converted 
into potentially harmful oxidation products or subjected to 
in vitro oxidative degradation resulting in the formation of 
an ortho-quinone and the subsequent production of ROS 
(i.e., superoxide and hydrogen peroxide; Boots et al., 
2003). The resultant prooxidant properties of quercetin are 
responsible for its mutagenic and cytotoxic effects (Sahu 
 
  
1 - primary vascular radial bone tissue, 2 - several secondary osteons form irregular Haversian bone tissue,  
3 - Volkmann’s canals, 4 - primary vascular longitudinal bone tissue 
Figure 1 Microstructure of femoral bone in rabbits from 
control (C) group. 
Figure 2 Microstructure of femoral bone in rabbits  from 
experimental (E) group. 
 
Potravinarstvo
®
 Scientific Journal for Food Industry 
Volume 10 303  No. 1/2016 
and Washington, 1991; Soria et al., 2010). So, it can 
indicate toxicity in that case, such as an induction of 
apoptosis of osteoblasts (Notoya et al., 2003; Spencer et 
al., 2003; Son et al., 2008). 
 From histomorphometrical point of view, 200 vascular 
canals of primary osteons, 200 Haversian canals, and 
200 secondary osteons were measured in rabbits from E 
and C groups. The results are summarized in Tables 1, 2 
and 3. The values for measured parameters (area, 
perimeter, maximum and minimum diameters) of primary 
osteons’ vascular canals and secondary osteons (except for 
their maximum diameters) were significantly lower  
(p <0.05) in rabbits from E group. The values from 
parameters of Haversian canals did not differ between both 
groups of rabbits. The primary osteons’ vascular canals 
constriction in rabbits from E group can be related to the 
adverse effect ofquercetin on blood vessels, which provide 
bone nutrition (Greenlee and Dunnell, 2010). According 
to Pries et al. (2005), blood vessels are able to adapt its 
structure (vascular remodeling) as a response to 
continuous functional changes. In vitro studies (Leikert et 
al., 2002; Huisman et al., 2004; Wallerath et al., 2005; 
Jackson and Venema, 2006; Schmitt and Dirsch, 2009) 
suggest an adverse effect of quercetin on the enzyme nitric 
oxidesynthase (eNOS) expression and endothelial nitric 
oxide (NO) production. NO acts as a potential 
vasodilator,and itcontributes to the migration and growth 
of endothelial cells necessary for initiation of angiogenesis 
in vivo (Carmeliet, 2000; Jackson and Venema, 2006). 
We suppose that alterations in the size of primary osteons’ 
vascular canals in rabbits from E and C groups are 
connected with an adverse effect of quercetin on the 
expression of eNOS. 
 We assume that significant differences (p <0.05) in the 
size of secondary osteons between rabbits from E and C 
groups may be associated with the destruction of collagen 
fibers which are present in the osteons (Dylevský, 2007). 
Kang et al. (2001) found that quercetin significantly 
inhibited collagens I and III expression and had a growth-
inhibitory effect on keloid-derived fibroblasts. The adverse 
impact of various concentrations of quercetin (20, 40, and 
80 µmol.l-1) on human fibroblasts examined Stipcevic et 
al. (2006). According to these authors, the administration 
of the highest dose of quercetin leads to significantly 
decreased collagen concentration (more than 50%) in 
fibroblasts. We supports that similar effect could also been 
observed in osteoblasts.  
 
CONCLUSION 
 The study indicates that intramuscular application of 
quercetin at dose 1000 μg.kg-1 bw for 90 days, 3 times per 
week caused significant changes in qualitative and 
quantitative histological characteristics of the compact 
bone tissue in male rabbits. Rabbits exposed to quercetin 
had a lower number of secondary osteons in the middle 
part of the substantia compacta, and disposed thicker layer 
of primary vascular longitudinal bone tissue (periost and 
middle part of the bone). Histomorphometrical evaluations 
Table 1 Data on vascular canals of primary osteons in male rabbits from C and E groups. 
Rabbit's 
group 
N 
Area 
(µm2) 
Perimeter 
(µm) 
Max. diameter 
(µm) 
Min. diameter 
(µm) 
C 80 344.68 ±50.07 66.43 ±4.78 11.48 ±0.99 9.60 ±0.98 
E 120 317.35 ±51.82 63.80 ±5.11 11.10 ±1.00 9.13 ±1.00 
t-test p <0.05 p <0.05 NS p <0.05 
Note: N: number of measured structures; NS: non-significant changes. 
 
Table 2 Data on Haversian canals in male rabbits from C and E groups. 
Rabbit's 
group 
N 
Area 
(µm2) 
Perimeter 
(µm) 
Max. diameter 
(µm) 
Min. diameter 
(µm) 
C 80 322.15 ±65.07 64.25 ±6.53 11.13 ±1.35 9.20 ±1.19 
E 120 301.32 ±56.49 62.20 ±6.06 10.82 ±1.37 8.90 ±0.98 
t-test NS NS NS NS 
Note: N: number of measured structures; NS: non-significant changes. 
 
Table 3 Data on secondary osteons in male rabbits from C and E groups. 
Rabbit's 
group 
N 
Area 
(µm2) 
Perimeter 
(µm) 
Max. diameter 
(µm) 
Min. diameter 
(µm) 
C 80 5979.63 ±2816.19 273.19 ±60.51 47.97 ±11.30 38.12 ±9.18 
E 120 4629.72 ±1888.92 244.67 ±45.93 43.81 ±8.79 32.86 ±8.00 
t-test p <0.05 p <0.05 NS p <0.05 
Note: N: number of measured structures; NS: non-significant changes. 
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showed significantly decreased sizes of primary osteons’ 
vascular canals and secondary osteons in males from the E 
group. Our article provides initial information of the 
impact of quercetin on femoral bone microstructure in 
experimental animals. 
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